Dimethylformamide → HCID 77357100, compound
Reaction equation
C([N:3]([CH2:6][CH3:7])[CH2:4][CH3:5])C.[NH2:8][C:9]1[CH:10]=[C:11]([C:15]2[C:16](=[O:22])[N:17]([CH3:21])[CH2:18][C:19]=2[OH:20])[CH:12]=[CH:13][CH:14]=1.[CH3:23][N:24]([CH3:27])[CH:25]=[O:26]>>[CH2:11]1[CH2:12][CH:5]([C:4]2([NH:17][C:16]([NH:8][C:9]3[CH:14]=[CH:13][CH:12]=[C:11]([C:15]4[C:16](=[O:22])[N:17]([CH3:21])[CH2:18][C:19]=4[OH:20])[CH:10]=3)=[O:22])[N:3]=[CH:6][C:7]3[CH:13]=[CH:14][CH:9]=[CH:10][C:23]=3[N:24]([CH3:27])[C:25]2=[O:26])[CH2:18][CH2:19][CH2:15]1Participants
Conditions
- Temperature
- 50 °C
Procedure
A solution of 5-cyclohexyl-l,3-dihydro-1-methyl-3(R,S)-[(4-nitrohenyloxycarbonyl)amino]-2H-1,4-benzodiazepin-2-one (Example 1, Step 9) (400 mg, 0.92 mmol) in anhydrous dimethylformamide (5.5 ml), under an atmosphere of nitrogen, at ambient temperature, was treated with triethylamine (126 μl 0.92 mmol). After stirring for 5 min, a solution of 3-(3-aminophenyl)-1,5-dihydro-4-hydroxy-N-methyl-2H-pyrrol-2-one (187 mg, 0.92 mmol) in anhydrous dimethylformamide (5.5 ml) was added dropwise. The solution was then heated at 50° C. for 2 h. The solution was cooled to room temperature and the solvent evaporated in vacuo. The residue was partitioned between ethyl acetate (20 ml) and 20% aqueous acetic acid (20 ml). The undissolved solid was filtered off and triturated with ether (20 ml) then hot methanol (20 ml), to afford the title compound (139 mg, 30%) as a white solid. mp 199°-201° C. 1H NMR (360MHz, D6 -DMSO) δ0.91 (1H, m), 1.09-1.93 (9H, m), 2.90 (4H, m), 3.31 (3H, s), 3.91 (2H, s), 5.07 (1H, d, J=8Hz), 7.13 (1H, t, J=8Hz), 7.23 (1H, d, J=8Hz), 7.36 (2H, m), 7.54 (2H, m), 7.63 (1H, m), 7.75 (1H, d, J=8Hz), 7.84 (1H, s), 8.96 (1H, s).
Workup
- temperatureThe solution was cooled to room temperature
- customthe solvent evaporated in vacuo
- customThe residue was partitioned between ethyl acetate (20 ml) and 20% aqueous acetic acid (20 ml)
- filtrationThe undissolved solid was filtered off
- customtriturated with ether (20 ml)
Sources & evidence
- ORD record
- ord-5e2a2f28bbd44ce7ba56adeaf3b22216
- Source dataset
- uspto-grants-1995_04
- Patent number
- US05410049
Reaction notes
Loading…